Skip Nav Destination
Issues
15 August 2013
-
Cover Image
Cover Image
The cover shows Rad51 foci (red) in pancreatic cancer cells treated with gemcitabine and radiation. Nuclei are stained with DAPI (blue). For details, see the article by Engelke and colleagues on page 4412 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR Perspectives in Drug Approval
Molecular Pathways
Reviews
Author Choice
Impact of Bioinformatic Procedures in the Development and Translation of High-Throughput Molecular Classifiers in Oncology
Charles Ferté; Andrew D. Trister; Erich Huang; Brian M. Bot; Justin Guinney; Frederic Commo; Solveig Sieberts; Fabrice André; Benjamin Besse; Jean-Charles Soria; Stephen H. Friend
Human Cancer Biology
Cancer Therapy: Preclinical
Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features
Loretta Gammaitoni; Lidia Giraudo; Valeria Leuci; Maja Todorovic; Giulia Mesiano; Franco Picciotto; Alberto Pisacane; Alessandro Zaccagna; Maria Giuseppa Volpe; Susanna Gallo; Daniela Caravelli; Elena Giacone; Tiziana Venesio; Antonella Balsamo; Ymera Pignochino; Giovanni Grignani; Fabrizio Carnevale-Schianca; Massimo Aglietta; Dario Sangiolo
Author Choice
Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
Michele Moschetta; Antonio Basile; Arianna Ferrucci; Maria Antonia Frassanito; Luigia Rao; Roberto Ria; Antonio Giovanni Solimando; Nicola Giuliani; Angelina Boccarelli; Fabio Fumarola; Mauro Coluccia; Bernardo Rossini; Simona Ruggieri; Beatrice Nico; Eugenio Maiorano; Domenico Ribatti; Aldo M. Roccaro; Angelo Vacca
Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776
Carl G. Engelke; Leslie A. Parsels; Yushen Qian; Qiang Zhang; David Karnak; Jordan R. Robertson; Daria M. Tanska; Dongping Wei; Mary A. Davis; Joshua D. Parsels; Lili Zhao; Joel K. Greenson; Theodore S. Lawrence; Jonathan Maybaum; Meredith A. Morgan
Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair
Dongping Wei; Leslie A. Parsels; David Karnak; Mary A. Davis; Joshua D. Parsels; Amanda C. Marsh; Lili Zhao; Jonathan Maybaum; Theodore S. Lawrence; Yi Sun; Meredith A. Morgan
Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12
Cuiling Zhong; Jianyong Wang; Bing Li; Hong Xiang; Mark Ultsch; Mary Coons; Terence Wong; Nancy Y. Chiang; Suzy Clark; Robyn Clark; Leah Quintana; Peter Gribling; Eric Suto; Kai Barck; Racquel Corpuz; Jenny Yao; Rashi Takkar; Wyne P. Lee; Lisa A. Damico-Beyer; Richard D. Carano; Camellia Adams; Robert F. Kelley; Weiru Wang; Napoleone Ferrara
A Novel Aldehyde Dehydrogenase-3 Activator (Alda-89) Protects Submandibular Gland Function from Irradiation without Accelerating Tumor Growth
Nan Xiao; Hongbin Cao; Che-Hong Chen; Christina S. Kong; Rehan Ali; Cato Chan; Davud Sirjani; Edward Graves; Albert Koong; Amato Giaccia; Daria Mochly-Rosen; Quynh-Thu Le
Imaging, Diagnosis, Prognosis
Cancer Therapy: Clinical
Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers
Laleh Amiri-Kordestani; Victoria Luchenko; Cody J. Peer; Kambiz Ghafourian; James Reynolds; Deb Draper; Robin Frye; Sue Woo; David Venzon; John Wright; Monica Skarulis; William D. Figg; Tito Fojo; Susan E. Bates; Richard L. Piekarz
Author Choice
Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor
Yusuke Tomita; Akira Yuno; Hirotake Tsukamoto; Satoru Senju; Yasuhiro Kuroda; Masatoshi Hirayama; Atsushi Irie; Kenta Kawahara; Junji Yatsuda; Akinobu Hamada; Hirofumi Jono; Koji Yoshida; Takuya Tsunoda; Hirotsugu Kohrogi; Yoshihiro Yoshitake; Yusuke Nakamura; Masanori Shinohara; Yasuharu Nishimura
Predictive Biomarkers and Personalized Medicine
Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
Gunter von Minckwitz; Wolfgang D. Schmitt; Sibylle Loibl; Berit M. Müller; Jens U. Blohmer; Bruno V. Sinn; Holger Eidtmann; Wolfgang Eiermann; Bernd Gerber; Hans Tesch; Jörn Hilfrich; Jens Huober; Tanja Fehm; Jana Barinoff; Thomas Rüdiger; Erhard Erbstoesser; Peter A. Fasching; Thomas Karn; Volkmar Müller; Christian Jackisch; Carsten Denkert
Letter to the Editor
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds